Trial · NCT00515879
Results by group28
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 28
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Social Phobic Disorders Severity and Change Form | D-cycloserine-augmented CBT | 2.68 | 95% Confidence Interval 2.38 to 2.98 | Units on a scale | |
| Social Phobic Disorders Severity and Change Form | Placebo-augmented CBT | 2.95 | 95% Confidence Interval 2.64 to 3.27 | Units on a scale | |
| Liebowitz Social Anxiety Scale (LSAS) | D-cycloserine-augmented CBT | 39.19 | 95% Confidence Interval 34.79 to 43.59 | LSAS scores | |
| Liebowitz Social Anxiety Scale (LSAS) | Placebo-augmented CBT | 42.44 | 95% Confidence Interval 37.94 to 47.03 | LSAS scores | |
| Social Phobia and Anxiety Inventory | D-cycloserine-augmented CBT | 3 Months | 71.08 | Standard Deviation 28.585 | score on a scale |
| Social Phobia and Anxiety Inventory | Placebo-augmented CBT | 3 Months | 73.74 | Standard Deviation 30.311 | score on a scale |
| Social Phobia and Anxiety Inventory | D-cycloserine-augmented CBT | 6 Months | 69.64 | Standard Deviation 32.188 | score on a scale |
| Social Phobia and Anxiety Inventory | Placebo-augmented CBT | 6 Months | 71.97 | Standard Deviation 30.566 | score on a scale |
| Social Phobia and Anxiety Inventory | D-cycloserine-augmented CBT | 9 Months | 67.67 | Standard Deviation 31.847 | score on a scale |
| Social Phobia and Anxiety Inventory | Placebo-augmented CBT | 9 Months | 67.74 | Standard Deviation 33.289 | score on a scale |
| Quality of Life Enjoyment and Satisfaction Questionnaire | D-cycloserine-augmented CBT | 3 Months | 67.77 | Standard Deviation 14.075 | percentage of maximum |
| Quality of Life Enjoyment and Satisfaction Questionnaire | Placebo-augmented CBT | 3 Months | 67.44 | Standard Deviation 14.00 | percentage of maximum |
| Quality of Life Enjoyment and Satisfaction Questionnaire | D-cycloserine-augmented CBT | 6 Months | 66.32 | Standard Deviation 16.066 | percentage of maximum |
| Quality of Life Enjoyment and Satisfaction Questionnaire | Placebo-augmented CBT | 6 Months | 67.44 | Standard Deviation 14.872 | percentage of maximum |
| Quality of Life Enjoyment and Satisfaction Questionnaire | D-cycloserine-augmented CBT | 9 Months | 67.08 | Standard Deviation 16.063 | percentage of maximum |
| Quality of Life Enjoyment and Satisfaction Questionnaire | Placebo-augmented CBT | 9 Months | 69.58 | Standard Deviation 11.761 | percentage of maximum |
| Liebowitz Self-Rated Disability Scale | CBT Plus D-cycloserine | 3 Months | 15.6117 | Standard Deviation 7.25681 | score on a scale |
| Liebowitz Self-Rated Disability Scale | CBT Plus Placebo | 3 Months | 14.0303 | Standard Deviation 7.79688 | score on a scale |
| Liebowitz Self-Rated Disability Scale | CBT Plus D-cycloserine | 6 Months | 15.5283 | Standard Deviation 7.03686 | score on a scale |
| Liebowitz Self-Rated Disability Scale | CBT Plus Placebo | 6 Months | 14.4977 | Standard Deviation 7.98470 | score on a scale |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00515879/results